Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Initiation of Insulin Aspart in Type 2 Diabetes
NCT00572806Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Feb 2003
- Primary completion
- Feb 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Feb 2003; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00572806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00572806.